Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maju Mathews

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Early Intervention in Psychiatry|September 14, 2019
Evaluation of paliperidone palmitate long-acting injectable antipsychotic therapy as an early treatment option in patients with schizophreniaBrianne Brown, Ibrahim Turkoz, Branislav Mancevski, et al.
The Annals of Pharmacotherapy|January 25, 2007
Mirtazapine-associated dose-dependent and asymptomatic elevation of hepatic enzymesBabatunde Adetunji, Biju Basil, Maju Mathews, et al.
Journal of Clinical Psychopharmacology|July 21, 2006
Should the Physician's Desk Reference contraindicate the use of chlorpromazine-fluoxetine combination? A case reportBabatunde Adetunji, Biju Basil, Maju Mathews, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|June 30, 2007
Psychosis Precipitated by Acetyl-l-Carnitine in a Patient With Bipolar DisorderHarun Evcimen, Irakli Mania, Maju Mathews, et al.
Current Medical Research and Opinion|October 17, 2013
Early and sustained improvement with vilazodone in adult patients with major depressive disorder: post hoc analyses of two phase III trialsRakesh Jain, Dalei Chen, John Edwards, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|January 25, 2007
Mirtazapine-induced nightmaresMaju Mathews, Biju Basil, Harun Evcimen, et al.
International Clinical Psychopharmacology|December 16, 2014
Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trialMaju Mathews, Carl Gommoll, Dalei Chen, et al.
Psychiatry (Edgmont (Pa. : Township))|December 2, 2010
Is there evidence for effectiveness of transcranial magnetic stimulation in the treatment of psychiatric disorders?Biju Basil, Jamal Mahmud, Maju Mathews, et al.
The Journal of Clinical Psychiatry|May 3, 2006
Methodological issues in a study of long-term maintenance therapy with quetiapine versus haloperidol decanoateBabatunde Adetunji, Biju Basil, Maju Mathews, et al.
The Primary Care Companion for CNS Disorders|June 8, 2017
A Case of Caffeine Intolerance With Long-Term Use of FluoxetineFaraz Jamal, Aishwarya Durgam, Genesy Aickareth, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Early Intervention in Psychiatry|September 14, 2019
Evaluation of paliperidone palmitate long-acting injectable antipsychotic therapy as an early treatment option in patients with schizophreniaBrianne Brown, Ibrahim Turkoz, Branislav Mancevski, et al.
The Annals of Pharmacotherapy|January 25, 2007
Mirtazapine-associated dose-dependent and asymptomatic elevation of hepatic enzymesBabatunde Adetunji, Biju Basil, Maju Mathews, et al.
Journal of Clinical Psychopharmacology|July 21, 2006
Should the Physician's Desk Reference contraindicate the use of chlorpromazine-fluoxetine combination? A case reportBabatunde Adetunji, Biju Basil, Maju Mathews, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|June 30, 2007
Psychosis Precipitated by Acetyl-l-Carnitine in a Patient With Bipolar DisorderHarun Evcimen, Irakli Mania, Maju Mathews, et al.
Current Medical Research and Opinion|October 17, 2013
Early and sustained improvement with vilazodone in adult patients with major depressive disorder: post hoc analyses of two phase III trialsRakesh Jain, Dalei Chen, John Edwards, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|January 25, 2007
Mirtazapine-induced nightmaresMaju Mathews, Biju Basil, Harun Evcimen, et al.
International Clinical Psychopharmacology|December 16, 2014
Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trialMaju Mathews, Carl Gommoll, Dalei Chen, et al.
Psychiatry (Edgmont (Pa. : Township))|December 2, 2010
Is there evidence for effectiveness of transcranial magnetic stimulation in the treatment of psychiatric disorders?Biju Basil, Jamal Mahmud, Maju Mathews, et al.
The Journal of Clinical Psychiatry|May 3, 2006
Methodological issues in a study of long-term maintenance therapy with quetiapine versus haloperidol decanoateBabatunde Adetunji, Biju Basil, Maju Mathews, et al.
The Primary Care Companion for CNS Disorders|June 8, 2017
A Case of Caffeine Intolerance With Long-Term Use of FluoxetineFaraz Jamal, Aishwarya Durgam, Genesy Aickareth, et al.
Pageof 10